Drug Shortage Report for PENTHROX

Last updated on 2022-05-09 History
Report ID 152493
Drug Identification Number 02474719
Brand name PENTHROX
Common or Proper name Methoxyflurane Volatile liquid for inhalation
Company Name ENDO VENTURES LTD.
Market Status MARKETED
Active Ingredient(s) METHOXYFLURANE
Strength(s) 99.9%
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging size 3ml 10's
ATC code N02BG
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-01-12
Actual start date 2022-01-12
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-05-09
Company comments We wish to advise that MDI and Purdue Pharma (Canada) have terminated their commercial arrangement respecting the distribution of Penthrox® (methoxyflurane) in Canada. MDI is transitioning the distribution rights for Penthrox® to a new distributor, namely, Paladin Labs. Paladin Labs will require certain licenses and approvals to distribute Penthrox® in Canada. During the transition process, Penthrox® will not be available in the market for a period of time. Paladin Labs will provide further communication to keep you informed as the transition progresses and as stock becomes readily available. We apologize for any inconvenience and thank you for your on-going support of Penthrox®.
Health Canada comments
Tier 3 Status No
Contact Address 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD
BALLSBRIDGE, DUBLIN
IRELAND D04 H9P8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-05-09 French Compare
v7 2022-05-09 English Compare
v6 2022-02-03 French Compare
v5 2022-02-03 English Compare
v4 2022-02-03 English Compare
v3 2022-01-13 English Compare
v2 2022-01-12 French Compare
v1 2022-01-12 English Compare

Showing 1 to 8 of 8